Status | Study |
RECRUITING |
Study Name: A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function Condition: Hepatic Insufficiency Date: 2022-06-27 Interventions: Administered orally. |
RECRUITING |
Study Name: A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies Condition: Hepatic Insufficiency Date: 2022-01-13 Interventions: Specified dose on specified days |
Recruiting |
Study Name: Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies Condition: Hepatic Insufficiency Date: 2016-04-25 Interventions: Device: Hepatobiliary scintigraphy hepatobiliary scintigraphy with functional assessment of the future r |
Completed |
Study Name: Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers Condition: Hepatic Insufficiency Date: 2014-10-15 Interventions: Drug: BIIL 284 BS |
Completed |
Study Name: Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency Condition: Hepatic Insufficiency Date: 2014-09-23 Interventions: Drug: Tipranavir (TPV) Drug: Ritonavir (r) |
Completed |
Study Name: Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers Condition: Hepatic Insufficiency Date: 2014-07-14 Interventions: Drug: Nintedanib Soft gelatine capsule |
Completed |
Study Name: Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects Condition: Hepatic Insufficiency Date: 2014-07-04 Interventions: Drug: BI 1356 |
Completed |
Study Name: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function Condition: Hepatic Insufficiency Date: 2014-06-20 Interventions: Drug: Dabigatran etexilate |
Completed |
Study Name: Extracorporeal Photopheresis After Liver Transplant Condition: Hepatic Insufficiency Date: 2013-09-19 Interventions: Procedure: Extracorporeal photopheresis Extracorporeal photopheresis with Methoxsalen(UVADEX)and immunos |
Completed |
Study Name: Single Dose of 9-cis-retinoic Acid in Hepatic Patients Condition: Hepatic Insufficiency Date: 2013-06-21 Interventions: Drug: 9-cis-retinoic acid Single dose of 9-cis-retinoic acid (Capsule 30 mg) as oral exposure |